We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$52.3B
AUM Growth
+$4.34B
(+9%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IS
ironSource Ltd.
IS
|
+$136M |
| 2 |
Tesla
TSLA
|
+$119M |
| 3 |
Verizon
VZ
|
+$109M |
| 4 |
Home Depot
HD
|
+$101M |
| 5 |
Pfizer
PFE
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$247M |
| 2 |
Intel
INTC
|
+$216M |
| 3 |
Ford
F
|
+$145M |
| 4 |
General Motors
GM
|
+$143M |
| 5 |
Micron Technology
MU
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.22% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
1601
DELISTED
Akero Therapeutics
AKRO
| $535K | ﹤0.01% |
25,285
| – | – |
|
|
BBBY
1602
Bed Bath & Beyond
BBBY
$503M
| $535K | ﹤0.01% |
+9,977
| New | +$754K |
|
1603
Community Health Systems
CYH
$393M
| $535K | ﹤0.01% |
40,190
-69,710
| -63% | -$876K |
|
|
HIBB
1604
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $533K | ﹤0.01% |
7,409
-15,920
| -68% | -$1.27M |
|
|
ENV
1605
DELISTED
ENVESTNET, INC.
ENV
| $532K | ﹤0.01% |
6,700
+1,100
| +20% | +$89.5K |
|
|
FOLD
1606
DELISTED
Amicus Therapeutics
FOLD
| $531K | ﹤0.01% |
+46,000
| New | +$513K |
|
1607
Hilton Grand Vacations
HGV
$4.14B
| $530K | ﹤0.01% |
+10,170
| New | +$509K |
|
1608
Heartland Express
HTLD
$1.04B
| $530K | ﹤0.01% |
31,524
-11,730
| -27% | -$197K |
|
|
AMWD
1609
DELISTED
American Woodmark
AMWD
| $529K | ﹤0.01% |
8,111
-7,290
| -47% | -$494K |
|
|
INN
1610
Summit Hotel Properties
INN
$743M
| $528K | ﹤0.01% |
54,100
| – | – |
|
1611
Goosehead Insurance
GSHD
$1.63B
| $526K | ﹤0.01% |
+4,040
| New | +$580K |
|
1612
Matsons
MATX
$6.15B
| $526K | ﹤0.01% |
5,843
-25,940
| -82% | -$2.21M |
|
1613
Leslie's
LESL
$9.83M
| $524K | ﹤0.01% |
+1,108
| New | +$478K |
|
1614
Ralph Lauren
RL
$22.5B
| $524K | ﹤0.01% |
4,410
-5,537
| -56% | -$665K |
|
1615
Biomea Fusion
BMEA
$90.4M
| $522K | ﹤0.01% |
70,000
| – | – |
|
1616
KE Holdings
BEKE
$17.7B
| $519K | ﹤0.01% |
25,800
| – | – |
|
1617
Lindsay Corp
LNN
$1.17B
| $518K | ﹤0.01% |
3,405
-7,030
| -67% | -$1.07M |
|
|
POLY
1618
DELISTED
Plantronics, Inc.
POLY
| $516K | ﹤0.01% |
17,581
-14,040
| -44% | -$388K |
|
1619
Editas Medicine
EDIT
$402M
| $514K | ﹤0.01% |
+19,360
| New | +$666K |
|
|
MCHB
1620
Mechanics Bancorp
MCHB
$3.51B
| $514K | ﹤0.01% |
9,888
-26,930
| -73% | -$1.3M |
|
1621
MarineMax
HZO
$782M
| $508K | ﹤0.01% |
8,607
-22,990
| -73% | -$1.23M |
|
|
ECOL
1622
DELISTED
US Ecology, Inc.
ECOL
| $508K | ﹤0.01% |
15,908
-7,560
| -32% | -$250K |
|
1623
Mueller Industries
MLI
$14.7B
| $507K | ﹤0.01% |
34,132
-125,800
| -79% | -$1.7M |
|
|
INVX
1624
Innovex International
INVX
$1.79B
| $502K | ﹤0.01% |
25,503
-22,130
| -46% | -$487K |
|
1625
Lightspeed Commerce
LSPD
$1.41B
| $501K | ﹤0.01% |
12,400
+7,900
| +176% | +$539K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
- Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
- Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
- Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
- Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
- Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
- Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.
Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.